FIBROGEN INC — Director's Dealing 2023

Jan 10, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2023-01-06

Reporting Person: Conterno Enrique A (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-01-06	Common Stock	S	1538	$19.95	Disposed	295483	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	27800	Indirect

Footnotes

F1: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.

F2: Includes one share acquired on November 15, 2022 through the Issuer's Employee Stock Purchase Plan.